BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36662585)

  • 1. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
    Shillingford SR; Bennett AM
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():617-636. PubMed ID: 36662585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14).
    Park JE; Park BC; Song M; Park SG; Lee DH; Park SY; Kim JH; Cho S
    Biochem Biophys Res Commun; 2009 Oct; 387(4):795-9. PubMed ID: 19646420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs.
    Tanoue T; Yamamoto T; Maeda R; Nishida E
    J Biol Chem; 2001 Jul; 276(28):26629-39. PubMed ID: 11359773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.
    Wu GS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):579-85. PubMed ID: 17717636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
    Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
    Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding.
    Shillingford S; Zhang L; Surovtseva Y; Dorry S; Lolis E; Bennett AM
    J Biol Chem; 2022 Dec; 298(12):102617. PubMed ID: 36272649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-specificity phosphatases: critical regulators with diverse cellular targets.
    Patterson KI; Brummer T; O'Brien PM; Daly RJ
    Biochem J; 2009 Mar; 418(3):475-89. PubMed ID: 19228121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen activated protein kinase phosphatases and cancer.
    Haagenson KK; Wu GS
    Cancer Biol Ther; 2010 Mar; 9(5):337-40. PubMed ID: 20139719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Tyrosine Phosphatases: Time to End the Stigma.
    Stanford SM; Bottini N
    Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
    He R; Zeng LF; He Y; Zhang S; Zhang ZY
    FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
    Seo H; Cho S
    Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
    Zhang ZY
    Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
    Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
    J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of protein kinase signaling by protein phosphatases and inhibitors.
    Zhang ZY; Zhou B; Xie L
    Pharmacol Ther; 2002; 93(2-3):307-17. PubMed ID: 12191622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery and protein tyrosine phosphatases.
    Blaskovich MA
    Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
    Pulido R; Stoker AW; Hendriks WJ
    Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent inhibition of protein tyrosine phosphatases.
    Ruddraraju KV; Zhang ZY
    Mol Biosyst; 2017 Jun; 13(7):1257-1279. PubMed ID: 28534914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein.
    Masuda K; Shima H; Watanabe M; Kikuchi K
    J Biol Chem; 2001 Oct; 276(42):39002-11. PubMed ID: 11489891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Crosstalk Between Dual-Specific Phosphatases and Dual-Specific Protein Kinases Can Be A Potential Therapeutic Target for Anti-cancer Therapy.
    Celtikci B
    Adv Exp Med Biol; 2021; 1275():357-382. PubMed ID: 33539023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.